{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:13:26Z","timestamp":1757456006777,"version":"3.37.3"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003323","name":"ANRS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le SIDA et les H\u00e9patites Virales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1093\/jac\/dkv384","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T04:44:23Z","timestamp":1450413863000},"page":"783-793","source":"Crossref","is-referenced-by-count":2,"title":["Tenofovir DF\/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial"],"prefix":"10.1093","volume":"71","author":[{"given":"Olivier","family":"Lortholary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Roussillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Boucherie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Padoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Rami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Veziris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Patey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Caumes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Tod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,12,17]]},"reference":[{"key":"2016020508432107000_71.3.783.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00758.x"},{"key":"2016020508432107000_71.3.783.2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis203"},{"key":"2016020508432107000_71.3.783.3","unstructured":"European AIDS Clinical Society. Guidelines Version 6.0. Octobre 2011 . Brussels: EACS, 2011. http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js19813en\/ ."},{"key":"2016020508432107000_71.3.783.4","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . Washington: Department of Health and Human Services, 2013. https:\/\/aidsinfo.nih.gov\/guidelines ."},{"key":"2016020508432107000_71.3.783.5","first-page":"1203","article-title":"Tolerability of anti-tuberculosis treatment and HIV serostatus","volume":"11","author":"Lanternier","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2016020508432107000_71.3.783.6","doi-asserted-by":"publisher","DOI":"10.1086\/599114"},{"key":"2016020508432107000_71.3.783.7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832ec1f4"},{"key":"2016020508432107000_71.3.783.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70184-1"},{"key":"2016020508432107000_71.3.783.9","doi-asserted-by":"publisher","DOI":"10.1086\/518657"},{"key":"2016020508432107000_71.3.783.10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu046"},{"key":"2016020508432107000_71.3.783.11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-670-2_21"},{"key":"2016020508432107000_71.3.783.12","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200210000-00015"},{"key":"2016020508432107000_71.3.783.13","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.41.12.2670","article-title":"Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide","volume":"41","author":"Peloquin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2016020508432107000_71.3.783.14","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0222-8"},{"key":"2016020508432107000_71.3.783.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000131375.21070.06"},{"key":"2016020508432107000_71.3.783.16","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832f7b59"},{"key":"2016020508432107000_71.3.783.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2011.00954.x"},{"key":"2016020508432107000_71.3.783.18","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200408010-00006"},{"key":"2016020508432107000_71.3.783.19","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000135956.96166.f0"},{"key":"2016020508432107000_71.3.783.20","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183630.27665.30"},{"key":"2016020508432107000_71.3.783.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000196181.18916.9b"},{"key":"2016020508432107000_71.3.783.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.530"},{"key":"2016020508432107000_71.3.783.23","first-page":"360","article-title":"Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana","volume":"13","author":"Shipton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2016020508432107000_71.3.783.24","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241090-00004"},{"key":"2016020508432107000_71.3.783.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183519.45137.a6"},{"key":"2016020508432107000_71.3.783.26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/135965350801300507","article-title":"Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication","volume":"13","author":"Stohr","year":"2008","journal-title":"Antivir Ther"},{"key":"2016020508432107000_71.3.783.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl399"},{"key":"2016020508432107000_71.3.783.28","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1780"},{"key":"2016020508432107000_71.3.783.29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00492-09"},{"key":"2016020508432107000_71.3.783.30","doi-asserted-by":"publisher","DOI":"10.1310\/hct1203-171"},{"key":"2016020508432107000_71.3.783.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit246"},{"key":"2016020508432107000_71.3.783.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70007-0"},{"key":"2016020508432107000_71.3.783.33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05526-11"},{"key":"2016020508432107000_71.3.783.34","doi-asserted-by":"publisher","DOI":"10.1086\/498024"},{"key":"2016020508432107000_71.3.783.35","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0019"},{"key":"2016020508432107000_71.3.783.36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02379-13"},{"key":"2016020508432107000_71.3.783.37","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1388"},{"key":"2016020508432107000_71.3.783.38","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443060-00003"},{"key":"2016020508432107000_71.3.783.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03940.x"},{"key":"2016020508432107000_71.3.783.40","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.5.503"},{"key":"2016020508432107000_71.3.783.41","doi-asserted-by":"publisher","DOI":"10.1086\/599040"},{"key":"2016020508432107000_71.3.783.42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02468-12"},{"key":"2016020508432107000_71.3.783.43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit352"},{"key":"2016020508432107000_71.3.783.44","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32814e6b08"},{"key":"2016020508432107000_71.3.783.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014181"},{"key":"2016020508432107000_71.3.783.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013911"},{"key":"2016020508432107000_71.3.783.47","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70711-X"},{"key":"2016020508432107000_71.3.783.48","doi-asserted-by":"publisher","DOI":"10.1086\/595985"},{"key":"2016020508432107000_71.3.783.49","first-page":"946","article-title":"Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources","volume":"10","author":"Colebunders","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2016020508432107000_71.3.783.50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350501000303","article-title":"Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis","volume":"10","author":"Michailidis","year":"2005","journal-title":"Antivir Ther"},{"key":"2016020508432107000_71.3.783.51","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328011efac"},{"key":"2016020508432107000_71.3.783.52","doi-asserted-by":"publisher","DOI":"10.1086\/630208"},{"key":"2016020508432107000_71.3.783.53","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000432456.14099.c7"},{"key":"2016020508432107000_71.3.783.54","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70026-8"},{"key":"2016020508432107000_71.3.783.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013607"},{"key":"2016020508432107000_71.3.783.56","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000311"},{"key":"2016020508432107000_71.3.783.57","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000030"},{"key":"2016020508432107000_71.3.783.58","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-5-201209040-00004"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/3\/783\/6992307\/dkv384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T19:03:35Z","timestamp":1653851015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,17]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,5]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1093\/jac\/dkv384"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv384","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published":{"date-parts":[[2015,12,17]]}}}